Logo

Affy Facility Closing Tops Most-Read GenomeWeb News Stories Last Week

Sep 18, 2006
 
NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Sept. 15.
 
1. Affymetrix to Shutter, Consolidate Massachusetts Manufacturing and Development Facility (from Sept. 14)
 
2. Hopkins Study Hints at Role for Next-Gen Methods in Cancer Genome Sequencing; ABI's Agencourt Platform to Be Validated (from Sept. 12)
 
3. MAQC Publishes Results of Large-Scale Comparative Microarray Study, Says Cross-Platform Data Are 'Reproducible and Comparable' (from Sept. 11)
 
4. NIH Picks Lung, Ovarian, and Brain Cancers for Cancer Genome Atlas Project (from Sept. 13)
 
5. Jury Awards Innogenetics $7M in HCV Patent Case Against Abbott (from Sept. 11)
Breaking News
The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.